Markets:

Overview

News

Currencies

International

Treasuries

Bicycle Therapeutics plc - American Depositary Shares (NQ:BCYC)

3.745 +0.135 (+3.74%)

Delayed Quote Updated: 1:17 PM EST, Nov 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Bicycle Therapeutics plc - American Depositary Shares

< Previous 1 2 3 4 Next >

The Great Migration: Why International Tech and Biotech Giants are Redomiciling to the Massachusetts Hub

December 23, 2025

The global financial landscape is witnessing a seismic shift as international corporations increasingly abandon their home markets to "onshore" in the United States. At the heart of this movement is...

Via MarketMinute

Topics Economy Initial Public Offering

4 Analysts Assess Bicycle Therapeutics: What You Need To Know ↗

August 12, 2025

Via Benzinga

Bicycle (BCYC) Q2 Revenue Falls 69% ↗

August 08, 2025

Via The Motley Fool

Topics Intellectual Property

Demystifying Bicycle Therapeutics: Insights From 7 Analyst Reviews ↗

July 17, 2025

Via Benzinga

Deep Dive Into Bicycle Therapeutics Stock: Analyst Perspectives (9 Ratings) ↗

February 26, 2025

Via Benzinga

Forecasting The Future: 11 Analyst Projections For Bicycle Therapeutics ↗

January 13, 2025

Via Benzinga

Breaking Down Bicycle Therapeutics: 8 Analysts Share Their Views ↗

December 16, 2024

Via Benzinga

A Glimpse Into The Expert Outlook On Bicycle Therapeutics Through 7 Analysts ↗

May 02, 2025

Via Benzinga

Analyst Expectations For Bicycle Therapeutics's Future ↗

April 09, 2025

Via Benzinga

Amazon To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

December 18, 2024

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 13, 2024

Via Benzinga

Candel Therapeutics, 8x8 And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

December 13, 2024

Via Benzinga

Navigating 11 Analyst Ratings For Bicycle Therapeutics ↗

October 24, 2024

Via Benzinga

In-Depth Examination Of 5 Analyst Recommendations For Bicycle Therapeutics ↗

September 06, 2024

Via Benzinga

The Latest Analyst Ratings For Bicycle Therapeutics ↗

August 07, 2024

Via Benzinga

Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients ↗

December 13, 2024

Bicycle Therapeutics presented data on zelenectide pevedotin, highlighting enhanced efficacy in cancer patients with NECTIN4 gene amplification.

Via Benzinga

BCYC: A Promising Play In The Biotech Sector ↗

October 01, 2024

The long-awaited and overdue half-point cut in the federal funds rate was the impetus for the SPDR Biotech ETF to finally break above the 102-103 level. Meanwhile, Bicycle Therapeutics Plc. had a...

Via Talk Markets

Topics ETFs

Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone ↗

September 06, 2024

RBC Capital initiates coverage on Bicycle Therapeutics, highlighting Zelenectide's potential in oncology with improved safety over competitors. The analyst projects ~$2 billion in peak sales by 2033...

Via Benzinga

BCYC Stock Earnings: Bicycle Therapeutics Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

BCYC stock results show that Bicycle Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Dow Dips Over 550 Points; BJ's Wholesale Club Earnings Beat Views ↗

May 23, 2024

Via Benzinga

Topics Earnings Stocks

Expert Ratings For Bicycle Therapeutics ↗

April 10, 2024

Via Benzinga

The Analyst Landscape: 4 Takes On Bicycle Therapeutics ↗

February 21, 2024

Via Benzinga

Forecasting The Future: 4 Analyst Projections For Bicycle Therapeutics ↗

December 20, 2023

Via Benzinga

Gold Falls Sharply; US Composite PMI Surges In May ↗

May 23, 2024

Via Benzinga

e.l.f. Beauty Posts Upbeat Earnings, Joins Nvidia, LiveRamp Holdings, Borr Drilling And Other Big Stocks Moving Higher On Thursday ↗

May 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 23, 2024

Via Benzinga

BCYC Stock Earnings: Bicycle Therapeutics Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

BCYC stock results show that Bicycle Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Walmart To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

February 21, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

February 13, 2024

Via Benzinga

Constellation Energy, Battalion Oil And Other Big Stocks Moving Higher On Friday ↗

December 15, 2023

U.S. stocks traded mixed, with the Nasdaq Composite gaining around 60 points on Friday. Here are some other big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.